Clindamycin
Product Images NDC 17478-121

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 17478-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cli0c 0011 01

FDA Label Image

Cli0c 0011 02

This is a description of a medication containing Clindamycin Phosphate. It is sterile, non-wrappable, and should not be exposed to temperatures above 30°C. The medication contains additional chemicals to adjust pH levels. The packaging does not recommend using it with any supplementary medication or in series connections. The prescription information provided should be referred to when determining the dosage. The medication is intended for rapid injection or IV push. The medication is produced by Akorn, Inc.*

FDA Label Image

Cli0c 0011 03

This is a description of a medication called Clindamycin in 5% dextrose solution, that should not be given rapidly or through IV push. Each 50 mL contains 300 mg of Clindamycin. The medication needs to be preserved at 20° to 25°C (68° to 77°F) in a controlled room away from excessive temperatures. The medication is sterile, non-pyrogenic, and manufactured by Akorn, Inc. There is additional information on the bottle that should be read before prescribing, including the non-use of supplementary medication or any connections.*

FDA Label Image

Cli0c 0011 04

This is a description of a Clindamycin injection, sold in a single dose bottle containing 600mg of Clindamycin equivalent to Clindamycin Phosphate. It is a sterile, non-pyrogenic solution to be used intravenously, and should not be administered via rapid injection or IV push. The bottle contains 50mL of the 5% Dextrose solution, and should be stored between 20° to 25°C. The manufacturer is Akorn, Inc., and the product comes with a set of cautions, including the prohibition of any supplementary medication, and it must not be used in series connections.*

FDA Label Image

Cli0c 0011 05

This is a description of a medicine with the NDC (National Drug Code) 17478-121-50. The medicine is clindamycin with sodium chloride and dextrose. It comes in a sterile and nonpyrogenic single-dose bottle of 50 mL. The caution given is not to add any supplementary medication and to use it only if the solution is clear. It is manufactured by AO Inc. The instructions state to avoid high temperatures and hydrochloric acid and the pH may need adjusting for intravenous use.*

FDA Label Image

Cli0c 0011 06

This is the description of a medication called Clindamycin in 5% Dextrose Injection. It comes in a 50 mL single-dose bottle and each dose contains 900 mg of Clindamycin. The medication should not be rapidly injected or given through IV push. It is for intravenous use only and must be stored at room temperature. The medication is sterile and non-pyrogenic. However, it should not be used in series connections and supplementary medication should not be added. Before administering, solution clarity should be checked.*

FDA Label Image

Cli0c 0011 07

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.